Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026)
Greater Cannabis Company has reported Change in Accured Expenses over the past 6 years, most recently at $20000.0 for Q4 2022.
- For Q4 2022, Change in Accured Expenses rose 160.91% year-over-year to $20000.0; the TTM value through Dec 2022 reached $60000.0, up 230.32%, while the annual FY2025 figure was $1627.0, 92.85% down from the prior year.
- Change in Accured Expenses for Q4 2022 was $20000.0 at Greater Cannabis Company, roughly flat from $20000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $55977.0 in Q4 2019 and troughed at -$55000.0 in Q1 2019.
- A 5-year average of $8366.9 and a median of $10062.5 in 2020 define the central range for Change in Accured Expenses.
- Biggest five-year swings in Change in Accured Expenses: plummeted 3614.38% in 2019 and later surged 4377.61% in 2022.
- Year by year, Change in Accured Expenses stood at -$24141.0 in 2018, then skyrocketed by 331.88% to $55977.0 in 2019, then plummeted by 71.42% to $16000.0 in 2020, then crashed by 305.22% to -$32836.0 in 2021, then skyrocketed by 160.91% to $20000.0 in 2022.
- Business Quant data shows Change in Accured Expenses for GCAN at $20000.0 in Q4 2022, $20000.0 in Q3 2022, and -$10000.0 in Q2 2022.